Phase 2 Study to Assess Safety & Tolerability of a Single Injection Into the Knee Joint of Two Different Doses of MSB-CAR001 Combined With Hyaluronan Compared to Hyaluronan Alone in Patients Who Have Undergone an ACL Reconstruction

Trial Profile

Phase 2 Study to Assess Safety & Tolerability of a Single Injection Into the Knee Joint of Two Different Doses of MSB-CAR001 Combined With Hyaluronan Compared to Hyaluronan Alone in Patients Who Have Undergone an ACL Reconstruction

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Rexlemestrocel-L (Primary) ; Hyaluronic acid
  • Indications Ligament injuries; Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Mesoblast
  • Most Recent Events

    • 15 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 01 Apr 2016 Results published in a Mesoblast media release.
    • 01 Apr 2016 Results from IIa portion of the trial were presented at the 2016 Osteoarthritis Research Society International (OARSI) World Congress, according to a Mesoblast media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top